Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IS IT THE CONCENSUS

Well, if it is not posted in the Gazzette, then the current volume and price will have been a clear indicator. The concensus seems to be....it is not worth risking any more money in advance of this happening. My question.... If it is posted, will it then bring in buyers and move the share price or will it just be viewed as redundant and not definitive due to the ongoing reexam?

Share
New Message
Please login to post a reply